TREATMENT OF PERSISTENT OR RECURRENT OVARIAN-CARCINOMA WITH SEQUENTIAL METHOTREXATE AND 5-FLUOROURACIL

被引：3

作者：

CHAMBERS, JT

SCHWARTZ, PE

机构：

来源：

GYNECOLOGIC ONCOLOGY | 1986年 / 23卷 / 03期

关键词：

D O I：

10.1016/0090-8258(86)90136-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：346 / 349

页数：4

共 27 条

[1]

ALLEGRA JC, 1983, SEMIN ONCOL, V10, P23

[2] 5 YEARS CLINICAL EXPERIENCE WITH 5-FLUOROURACIL [J].

ANSFIELD, FJ ;

CURRERI, AR ;

SCHROEDER, JM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1962, 181 (04) :295-+

[3] 2ND-LINE EFFICACY OF INTERMEDIATE HIGH-DOSE METHOTREXATE WITH CITROVORUM FACTOR RESCUE + CYCLOPHOSPHAMIDE IN OVARIAN-CANCER [J].

BARLOW, JJ ;

PIVER, MS .

GYNECOLOGIC ONCOLOGY, 1979, 7 (02) :233-238

[4] SCHEDULE-DEPENDENT CYTO-TOXICITY OF METHOTREXATE AND 5-FLUOROURACIL IN HUMAN-COLON AND BREAST-TUMOR CELL-LINES [J].

BENZ, C ;

SCHOENBERG, M ;

CHOTI, M ;

CADMAN, E .

JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (05) :1162-1165

[5]

BENZ C, 1982, CANCER RES, V42, P2081

[6]

BENZ C, 1983, CANCER TREAT REP, V67, P297

[7]

BENZ C, 1981, CANCER RES, V41, P994

[8]

BERTINO JR, 1977, CANCER RES, V37, P327

[9] ENHANCED 5-FLUOROURACIL NUCLEOTIDE FORMATION AFTER METHOTREXATE ADMINISTRATION - EXPLANATION FOR DRUG SYNERGISM [J].

CADMAN, E ;

HEIMER, R ;

DAVIS, L .

SCIENCE, 1979, 205 (4411) :1135-1137

[10]

CANTRELL JE, 1982, CANCER TREAT REP, V66, P1563

← 1 2 3 →